Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.
about
Complementary and Alternative Therapies in Amyotrophic Lateral SclerosisNew Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43.Mechanisms of amino acid-mediated lifespan extension in Caenorhabditis elegansTriheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral SclerosisALSUntangled: introducing The Table of Evidence.AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis.Ketogenic diet treatment increases longevity in Kcna1-null mice, a model of sudden unexpected death in epilepsyManagement and therapeutic perspectives in amyotrophic lateral sclerosis.Neurobehavioral testing in subarachnoid hemorrhage: A review of methods and current findings in rodents.Alternative Fuels in Epilepsy and Amyotrophic Lateral Sclerosis.Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic TreatmentsDegeneration of spinal motor neurons by chronic AMPA-induced excitotoxicity in vivo and protection by energy substrates.Diets for Patients with Amyotrophic Lateral Sclerosis: Pay Attention to Nutritional Intervention.Genetic induction of hypometabolism by ablation of MC4R does not suppress ALS-like phenotypes in the G93A mutant SOD1 mouse model.How Can a Ketogenic Diet Improve Motor Function?Metabolic Reprogramming in Amyotrophic Lateral Sclerosis.Non-invasive assessment of disease progression and neuroprotective effects of dietary coconut oil supplementation in the ALS SOD1 mouse model: A H-magnetic resonance spectroscopic study
P2860
Q26777929-17157B40-7A54-44F4-8615-5A5AEFEB3509Q33783000-06B23E57-4780-411C-8F96-DA892BE5FCB2Q35239387-071D3BF1-B00F-4948-BB42-FCCF9CB7F740Q35553753-82F9EF1F-6406-4311-B069-FD9A85DDF20FQ36114275-A74CF7BF-C794-4AFF-828D-0C57C9577334Q38302007-0FCE3C22-7058-4D6B-BC6D-B221404014E5Q38552413-76961C8C-05B8-472A-B6DA-D19D61400B21Q38848243-37F96317-60F9-4323-A97F-A3E4F8A77373Q38958585-DE409F5A-2EEF-4E26-A863-5E8FF1708C4CQ38966169-2D94CC5F-B993-415D-88A6-382EB9588472Q39014987-C46AC685-8BC8-451D-8952-A283A87D81E8Q39101800-3FA3C9C4-8545-4CB7-B6FF-3B4606586A75Q40609007-0801F6FC-E578-47C3-B70B-ED9D2EEE321FQ42343391-AC49CB2E-2719-4E34-9FF3-80FCA4BF9145Q42377167-94949110-40F7-4B15-ADCF-9DB8370BE760Q49620553-0DB98049-9EA9-4CD4-9052-2C5FE60F984CQ51736520-A2C85C01-0EC3-4AEE-A62B-9990C17410A9Q58126926-2F691789-9404-4777-9B45-618DE2D6922A
P2860
Metabolic therapy with Deanna Protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Metabolic therapy with Deanna ...... l sclerosis (ALS) mouse model.
@en
Metabolic therapy with Deanna ...... amyotrophic lateral sclerosis
@nl
type
label
Metabolic therapy with Deanna ...... l sclerosis (ALS) mouse model.
@en
Metabolic therapy with Deanna ...... amyotrophic lateral sclerosis
@nl
prefLabel
Metabolic therapy with Deanna ...... l sclerosis (ALS) mouse model.
@en
Metabolic therapy with Deanna ...... amyotrophic lateral sclerosis
@nl
P2093
P2860
P1433
P1476
Metabolic therapy with Deanna ...... l sclerosis (ALS) mouse model.
@en
P2093
Angela M Poff
Carol S Landon
Craig R Goldhagen
Csilla Ari
Dominic P D'Agostino
Heather E Held
Nicholas Mavromates
P2860
P304
P356
10.1371/JOURNAL.PONE.0103526
P407
P577
2014-07-25T00:00:00Z